These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34390114)

  • 1. Do valproate preparations improve agitation in dementia? A Cochrane Review summary with commentary.
    Lindley RI
    Australas J Ageing; 2021 Sep; 40(3):336-338. PubMed ID: 34390114
    [No Abstract]   [Full Text] [Related]  

  • 2. Valproate preparations for agitation in dementia.
    Lonergan E; Luxenberg J
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003945. PubMed ID: 19588348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid for agitation in dementia.
    Lonergan ET; Cameron M; Luxenberg J
    Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate in the treatment of behavioral agitation in elderly patients with dementia.
    Lott AD; McElroy SL; Keys MA
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):314-9. PubMed ID: 7580190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium valproate in the treatment of behavioral disturbance in dementia.
    Mellow AM; Solano-Lopez C; Davis S
    J Geriatr Psychiatry Neurol; 1993; 6(4):205-9. PubMed ID: 8251047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reversible dementia due to valproic acid therapy].
    Walstra GJ
    Ned Tijdschr Geneeskd; 1997 Feb; 141(8):391-3. PubMed ID: 9157301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of valproic acid in dementia: A systematic review with meta-analysis.
    Liu J; Wang LN
    Arch Gerontol Geriatr; 2020; 89():104091. PubMed ID: 32413690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid treatment of agitation in dementia.
    Herrmann N
    Can J Psychiatry; 1998 Feb; 43(1):69-72. PubMed ID: 9494750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of valproate and lithium on dementia onset risk in bipolar disorder patients.
    Moon W; Ji E; Shin J; Kwon JS; Kim KW
    Sci Rep; 2022 Aug; 12(1):14142. PubMed ID: 35986042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible rapidly progressive dementia with parkinsonism induced by valproate in a patient with systemic lupus erythematosus.
    Sleegers MJ; Beutler JJ; Hardon WJ; Berden JH; Verhave JC; Conemans JM; Hollander DA; Dautzenberg PL; Hoogeveen EK
    J Am Geriatr Soc; 2010 Apr; 58(4):799-801. PubMed ID: 20398172
    [No Abstract]   [Full Text] [Related]  

  • 11. Valproate-induced delirium in a demented patient.
    Gareri P; Lacava R; Cotroneo A; Bambara V; Marigliano N; Castagna A; Costantino DS; Ruotolo G; de Sarro G
    Arch Gerontol Geriatr; 2009; 49 Suppl 1():113-8. PubMed ID: 19836623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary bipolar disorder and Diogenes syndrome in frontotemporal dementia: behavioral improvement with quetiapine and sodium valproate.
    Gálvez-Andres A; Blasco-Fontecilla H; González-Parra S; Molina JD; Padín JM; Rodriguez RH
    J Clin Psychopharmacol; 2007 Dec; 27(6):722-3. PubMed ID: 18004150
    [No Abstract]   [Full Text] [Related]  

  • 13. Valproic acid in dementia: does an optimal dose exist?
    Dolder CR; Nealy KL; McKinsey J
    J Pharm Pract; 2012 Apr; 25(2):142-50. PubMed ID: 22095580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium valproate adjuvant therapy on patients with dementia: A protocol for systematic review and meta-analysis.
    Zhang CQ; Zheng KX; Sun LQ; Sun H
    Medicine (Baltimore); 2021 Dec; 100(51):e28161. PubMed ID: 34941069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of intravenous valproate in agitation: a systematic review.
    Olivola M; Civardi S; Damiani S; Cipriani N; Silva A; Donadeo A; Politi P; Brondino N
    Psychopharmacology (Berl); 2022 Feb; 239(2):339-350. PubMed ID: 34783884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosis-like absence status of elderly patients: successful treatment with sodium valproate.
    Iivanainen M; Bergström L; Nuutila A; Viukari M
    J Neurol Neurosurg Psychiatry; 1984 Sep; 47(9):965-9. PubMed ID: 6434700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychic disturbances associated with sodium valproate plus levetiracetam.
    Siniscalchi A; Gallelli L; De Fazio S; De Sarro G
    Ann Pharmacother; 2007 Mar; 41(3):527-8. PubMed ID: 17327289
    [No Abstract]   [Full Text] [Related]  

  • 18. Divalproex sodium therapy in elderly with dementia-related agitation.
    Pratt CE; Davis SM
    Ann Pharmacother; 2002 Oct; 36(10):1625-8. PubMed ID: 12243614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of sodium valproate on disturbed behavior in dementia.
    Sival RC; Haffmans PM; van Gent PP; van Nieuwkerk JF
    J Am Geriatr Soc; 1994 Aug; 42(8):906-7. PubMed ID: 8046208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.